Diagnostic News and Research

RSS

Thyroid treatments can set off radiation detectors

Medical procedures such as iodine therapy, a popular thyroid treatment, can result in patients triggering radiation detectors for up to three months after treatment, according to a study presented today at the annual meeting of the Radiological Society of North America (RSNA).

30 Nov 2004

Magnetic resonance spectroscopy may prove to be the definitive diagnostic test for bipolar disorder

Magnetic resonance (MR) spectroscopy may prove to be the definitive diagnostic test for bipolar disorder, a serious brain illness characterized by an alternating pattern of extreme emotional highs and lows, according to a study presented today at the annual meeting of the Radiological Society of North America (RSNA).

30 Nov 2004

Joint collaboration to fight avian influenza

Recognizing the pandemic potential and the threat to public health posed by the Avian Influenza, Health Ministers and senior officials of thirteen countries from Southeast and East Asian countries have pledged to accelerate joint collaboration in fighting the disease.

29 Nov 2004

Iris Murdoch's last novel reveals signs of the first stages of Alzheimer’s disease

The last novel written by author Iris Murdoch before she died reveals signs of the first stages of Alzheimer’s disease, according to a study published in the latest online issue of Brain.

29 Nov 2004

New virtual microscopy system

Researchers at the universities of Helsinki and Tampere (Finland) have developed a new virtual microscopy system, which allows users digitize entire microscope glass slide specimens, and then create a virtual slide with the quality and resolution similar to the original glass slide viewed on a microscope.

29 Nov 2004

Cancers of the head and neck cause over 2,700 deaths per year in England and Wales

Cancers of the head and neck cause over 2,700 deaths per year in England and Wales. Smoking and drinking cause most cancers of the mouth, lip and tongue (oral cavity), throat and voice box.

24 Nov 2004

Experimental compound prevents cholesterol gallstone disease

A promising experimental compound prevents cholesterol gallstone disease in mice by stimulating the biochemical pathway that controls bile acid secretion by the liver, according to new studies by Howard Hughes Medical Institute researchers.

23 Nov 2004

Early results shed light on lung cancer screening advance

One in three smokers or former smokers screened for lung cancer at a baseline and one year follow-up visit using a recent advance in computed tomography tested positive according to a new study. Of those, 12 percent had lung biopsies, and 7 percent were diagnosed with lung cancer.

23 Nov 2004

Capsules may be effective in treating bipolar disorder

University of North Carolina at Chapel Hill researchers have announced study results finding that a formulation of three-beaded extended-release carbamazepine capsules (ERC-CBZ) was effective, safe and tolerable in the treatment of bipolar I disorder

19 Nov 2004

Nanogen announces clinical diagnostic to simultaneously detect multiple respiratory viruses

Nanogen announced today that it is developing new analyte specific reagents (ASRs) for clinical reference laboratories to develop and validate a single test to detect six of the most common respiratory viruses.

10 Nov 2004

Heart arrhythmias easily treated, yet few know risks

Since she was a young girl, Sandra Moore, 46, of Glen Ellyn, Ill., had episodes every few months when her heart started racing.

9 Nov 2004

Neogen Europe have announced new tests to detect hazardous toxins in grains, wine, nuts and coffee

Neogen Europe Ltd. announced today the introduction of two new tests to detect hazardous toxins in grains, wine, nuts and coffee. Marketing has begun in Europe and the products will soon be available in the United States and other worldwide markets.

8 Nov 2004

Technology to determine a patient's response to aspirin therapy taken to prevent heart attacks

This technology has demonstrated the ability to assess an individual's relative risk for heart attack by measuring the person's degree of aspirin resistance.

8 Nov 2004

Australian alliance to commercialise new genetic tests for epilepsy

Bionomics Limited and Genetic Technologies Limited have formed a strategic alliance to commercialise new genetic tests for epilepsy. These new diagnostic tools will enable earlier diagnosis, more precise treatment and better overall outcomes for those suffering from inherited forms of epilepsy.

8 Nov 2004

Hong Kong reports case of H5N1 in dead bird

The Hong Kong Agriculture, Fisheries and Conservation Department (AFCD) has confirmed that a dead Grey Heron found in Lok Ma Chau area was tested positive for H5N1 virus.

4 Nov 2004

Researchers identify biomarkers that could lead to more accurate diagnosis of systemic lupus erythematosus

University of Pittsburgh researchers have identified biomarkers that could result in earlier and more accurate diagnosis of systemic lupus erythematosus (SLE), a devastating disease that affects as many as 1.5 million Americans, and occurs 10 to 15 times more frequently in women.

4 Nov 2004

The Bush Medicare Prescription has changed the identity of medical oncology

Under previous law, Medicare covered chemotherapy as well as radiation treatment for cancer patients, but did not pay for oral-dose anti-cancer drugs, unless they were available in both oral and injectable form.

4 Nov 2004

New non-invasive diagnostic test for early-stage lung cancer

A non-invasive diagnostic test for early-stage bronchial carcinoma (lung cancer) was presented at White Rose Bioscience Forum in York yesterday (03 November).

4 Nov 2004

Help for NHS staff bringing healthcare to the world's poor

NHS staff from England who are planning health projects in the world's poorest communities are being supported by a new Department of Health fund, now opening its second wave (3 November 2004).

3 Nov 2004

$73 million to tackle infectious diseases such as West Nile virus and influenza

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has awarded 14 contracts totaling more than $73 million to fund the Large-Scale Antibody and T Cell Epitope Discovery Program, an initiative aimed at quickly identifying the regions of selected infectious agents that elicit immune reactions.

1 Nov 2004